Mesenchymal stem cells attenuate keloid pathogenesis via TGF-β1/SMAD-driven MMP9 suppression: mechanistic insights

Yujia Zhao1, Hexiao Zhang2,3, Qiuyan Han1

  • 1Department of Plastic and Medical Aesthetic Surgery, The Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin 300211, China.

PubMed

Insights

Mesenchymal stem cells (MSCs) reduce keloid fibroblast activity by suppressing matrix metalloproteinases 9 (MMP9) via the transforming growth factor-β1/SMAD pathway. This study reveals MSCs

Area of Science:

  • Cell biology
  • Dermatology
  • Regenerative Medicine

Background:

  • Keloids present therapeutic challenges due to excessive collagen and recurrence.
  • Mesenchymal stem cells (MSCs) show promise for keloid treatment, but mechanisms are unclear.
  • Understanding MSCs' role in extracellular matrix (ECM) remodeling is crucial for keloid pathogenesis.

Purpose of the Study:

  • To investigate how MSCs modulate ECM remodeling in keloid pathogenesis.
  • To elucidate the specific molecular mechanisms by which MSCs affect keloid fibroblasts.
  • To identify potential therapeutic targets for keloid treatment.

Main Methods:

  • Co-culture of human umbilical cord MSCs (UC-MSCs) with immortalized keloid fibroblasts (HDIKFs).
  • Assays used: CCK8 for proliferation, wound healing for migration, quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) for gene expression.
  • Analysis of key signaling pathways: transforming growth factor-β1/SMAD (TGF-β1/SMAD), hypoxia-inducible factor-1α (HIF-1α), and interleukin-10 receptor alpha (IL-10RA).

Main Results:

  • UC-MSCs significantly suppressed keloid fibroblast proliferation and migration in vitro.
  • UC-MSCs selectively downregulated matrix metalloproteinases 9 (MMP9) expression in keloid fibroblasts.
  • Suppression of MMP9 was linked to inhibition of the TGF-β1/SMAD pathway, reduced HIF-1α and SMAD2, and increased IL-10RA.

Conclusions:

  • MSCs attenuate keloid fibroblast activity via TGF-β1/SMAD-driven MMP9 suppression and IL-10RA enhancement.
  • MMP9 is identified as a key therapeutic target for keloid management.
  • Findings provide a foundation for optimizing MSC-based therapies for ECM homeostasis in keloids.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Extracellular Matrix01:26

Extracellular Matrix

Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
5.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.1K